We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
109 hedge funds and large institutions have $662M invested in Lexicon Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 34 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
14% more capital invested
Capital invested by funds: $582M → $662M (+$80.2M)
0.72% more ownership
Funds ownership: 98.3% → 99.02% (+0.72%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less funds holding
Funds holding: 121 → 109 (-12)
15% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 34
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
67% less call options, than puts
Call options by funds: $939K | Put options by funds: $2.87M
Holders
109
Holders Change
-12
Holders Change %
-9.92%
% of All Funds
2.37%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
10
Increased
29
Reduced
34
Closed
19
Calls
$939K
Puts
$2.87M
Net Calls
-$1.93M
Net Calls Change
+$1.85M
Top Buyers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$8.86M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.91M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.38M |
| 4 |
First Manhattan
New York
|
+$1.21M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.09M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.33M |
| 2 |
SGA
Sector Gamma AS
Oslo,
Norway
|
-$2.09M |
| 3 |
D.E. Shaw & Co
New York
|
-$1.02M |
| 4 |
AIM
Assured Investment Management
New York
|
-$611K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$569K |
